Grossing revenues of Rs 1,000 crore in 2 years looks difficult
Negative judgment on sale of two diabetes drugs to have limited impact , as an alternative is ready
Significant recovery in share price unlikely soon, given the sluggish environment
Launches to improve market share
Re-rating unlikely, given gains from de-leveraging; margins and market share reflect in valuations
Start of the Dedicated Freight Corridor remains key re-rating trigger
Almost a third of the company's capex was stuck in this project
Operating profitability is looking up, but stock is at a significant premium to its peers
Domestic volumes must increase, if the stock wants to be re-rated significantly
Implementation of stricter emission norms and demand revival to boost the company
Launches and strong rental premiums should help stocks to outperform their peers
Street worried that Volkswagen recall in US could force Europe to impose stricter emission norms
Sale of hotels and non-core assets should bring down loans to manageable levels
New product launches, price cuts and resolution of production issues augur well for volume growth
Focus on shorter maturities amid global uncertainty and corporate bond mispricing helped Santosh Kamath and Kunal Agrawal reap gains
Buy quality, be patient and let earnings growth take care of returns, say R Janakiraman and Roshi Jain
Concerns over slowdown in North America heavy-truck market, lower demand from oil & gas segment
Mixed impact of spectrum trading norms, aggressive expansion by telcos a positive
Margins likely to move up from the current 20% levels; ideal time for an IPO, say analysts
Recent launches haven't arrested volume slide; company looks to raise market share